Myriad myPath Melanoma Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Myriad myPath Melanoma General Information

Description

Developer of genome tests designed to diagnose melanoma. The company offers gene-based tests for skin cancer diagnosis through improvement amendments certified clinical laboratory improvement amendments certified laboratory, giving the confidence to personalize patient treatment recommendations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 320 Wakara Way
  • Salt Lake City, UT 84108
  • United States
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 320 Wakara Way
  • Salt Lake City, UT 84108
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myriad myPath Melanoma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Myriad myPath Melanoma‘s full profile, request access.

Request a free trial

Myriad myPath Melanoma Patents

Myriad myPath Melanoma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220243275-A1 Genes and gene signature for diagnosis and treatment of melanoma Inactive 06-Jan-2016
CA-3010240-A1 Genes and gene signatures for diagnosis and treatment of melanoma Pending 06-Jan-2016
EP-3400312-A1 Genes and gene signatures for diagnosis and treatment of melanoma Inactive 06-Jan-2016
EP-3400312-A4 Genes and gene signatures for diagnosis and treatment of melanoma Inactive 06-Jan-2016
US-20190032144-A1 Genes and gene signatures for diagnosis and treatment of melanoma Inactive 06-Jan-2016 C12Q1/6886
To view Myriad myPath Melanoma’s complete patent history, request access »

Myriad myPath Melanoma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Myriad myPath Melanoma‘s full profile, request access.

Request a free trial

Myriad myPath Melanoma FAQs

  • Where is Myriad myPath Melanoma headquartered?

    Myriad myPath Melanoma is headquartered in Salt Lake City, UT.

  • What industry is Myriad myPath Melanoma in?

    Myriad myPath Melanoma’s primary industry is Diagnostic Equipment.

  • Is Myriad myPath Melanoma a private or public company?

    Myriad myPath Melanoma is a Private company.

  • What is the current valuation of Myriad myPath Melanoma?

    The current valuation of Myriad myPath Melanoma is .

  • What is Myriad myPath Melanoma’s current revenue?

    The current revenue for Myriad myPath Melanoma is .

  • Who are Myriad myPath Melanoma’s investors?

    Myriad Genetics has invested in Myriad myPath Melanoma.

  • When was Myriad myPath Melanoma acquired?

    Myriad myPath Melanoma was acquired on 28-May-2021.

  • Who acquired Myriad myPath Melanoma?

    Myriad myPath Melanoma was acquired by Castle Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process